Gupta, V. K., R. Giri, and S. Agrawal. “Dipeptidyl Peptidase-4 Inhibitor (teneligliptin) Significantly Reduces Liver Fat Content and Delays Progression of Non-Alcoholic Steatohepatitis in Type 2 Diabetes Mellitus Patients”. International Journal of Advances in Medicine, vol. 8, no. 12, Nov. 2021, pp. 1817-20, doi:10.18203/2349-3933.ijam20214516.